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Abstract 
 
Susceptibility to infection by the intracellular bacterial pathogen, Salmonella 
enterica serovar Typhimurium (S. typhimurium), is controlled by many genes of 
innate and adaptive immunity. One of the most critical genes is IFN- and mice 
deficient in IFN- synthesis are highly susceptible to Salmonella. Previously, we 
demonstrated that mice deficient in MyD88, an adaptor that regulates TLR signaling, 
are susceptible to Salmonella infection. In the current study, we compared immune 
responses in mice deficient in IFN- or MyD88 with wild-type controls following 
infection with an attenuated strain of S. typhimurium (designated BRD509E) or a 
recombinant derivative engineered to express murine IFN- (GIDIFN). Infection 
studies with BRD509E or GIDIFN revealed that the latter strain was significantly 
less virulent in immunodeficient mice than BRD509E and correlated with decreased 
bacterial loads in systemic organs. Enhanced responsiveness was due to GIDIFN 
strain’s ability to activate effector macrophages, as shown by increased synthesis of 
inflammatory cytokines and anti-microbial effector molecules, including NO. Gene 
expression profiling by qPCR demonstrated stronger induction of key inflammatory 
modulators by GIDIFN in macrophages of immunodeficient animals. These findings 
suggest that immunotherapeutic approaches using attenuated bacterial strains 
expressing immunomodulatory genes is more efficacious and offers a superior safety 
profile even in severely immunodeficient hosts.  
Keywords:  
IFNInnate immunity; Salmonella infection. 
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 )cibarA ni( tcartsbA dna eltiT
 
تحريض الإستجابات المناعية المضادة للميكروبات في نموذج حيواني منقوص 
. هذه  )-NFI(المناعة, عند تعرضه لبكتيريا السالمونيلا المنتجة للإنتفيرون جاما 
 . )segahporcaM(  البلعومية ة بتفعيل كفاءة الخلاياالإستجابة مرتبط
)،تعتمد على العديد muirumihpyt .Sقابلية الإصابة من قبل بكتيريا السالمونيلا  التيفية الفأرية (
والفئران الغير   -NFIمن جينات المناعة الفطرية والتكيفية. واحد من الجينات الأكثر أهمية هو 
 أثبتنا أن الفئران ابقلسالمونيلا. في الساللإصابة ببكتيريا  هم عرضة  -NFIقابلة لانتاج 
 هم أيضا معرضون ،))RLT الخلية مستقبلو هو محول ينظم إشارات ، 88DyM منقوصة
نقص  لاستجابات المناعية في الفئران ذواتقارنا ا . في الدراسة الحاليةبنفس الجرثومةللإصابة 
نيلا التيفية الفأرية (تسمى نوع مضعف من سلالة بكتيريا السالمو مع 88DyMأو   -NFIفي 
    ى(تسم  -NFIجنتامدعمة جينيا لإ)أو نوع آخر مشتق من السلالة السابقة 905DRB
بالبكتيريا القابلة لانتاج    -NFIذوات النقص في نإصابة الفئراو كشفت النتائج أن NFIDIG(.
اد البكتيريا الآخر، و قد كان مرتبطا بانخفاض في أعدكانت أقل ضررا من النوع  -NFI
 NFIDIGوقد ربطت هذه النتائج بسبب قدرة سلالة . دة في الأعضاء الداخلية للفئرانالمتواج
افرازالسيتوكينات من خلال زيادة إفراز ) segahporcaM(على تفعيل الخلايا البلعومية 
) والجزيئات المضادة للميكروبات، بما في ذلك senikotyc yrotammalfnI( الالتهابية
 ةبلعوميالخلايا ال أثبت أن )RCPq( لتعبير الجينياشير دراسة ت. )ON(تريك أوكسيد الني
من خلال تحويل نشاط هذه  NFIDIG -) لديها إستجابة أقوى لبكتيرياsegahporcaM(
 .هاز المناعيجي الفئران ذوات النقص في الف الخلايا بصورة أقوى إلى تفاعل مضاد للجراثيم 
هذه السلالة من البكتيريا القابلة على تغيير نمط باستخدام  ى أن النهج وتشير هذه النتائج إل 
أكثر كفاءة ص في الجهاز المناعي تعطي نتائج قالإستجابة المناعية للمرضى الذين يعانون من ن
 .و سلامة
 الكلمات المفتاحية:
 الإنتفيرون جاما، المناعة الفطرية، مرض السالمونيلا
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Chapter 1: Introduction 
Salmonella is an intra-macrophage pathogen that is transmitted through the 
oral route, causing a localized gastroenteritis, or a systemic typhoid fever or 
bacteremia. Salmonella colonizes the macrophages, and replicates inside the so-
called Salmonella containing vacuole (SCV). This capacity is regulated by the 
Salmonella pathogenicity island (SPI), an important virulence factor. Immunity to 
Salmonella is dependent on IFN-, a cytokine with powerful macrophage-activating 
properties that acts to induce their microbicidal potential. Moreover, IFN-functions 
to shift the antibody response to Th1-mediated isotypes, which includes IgG2a and 
IgG3, which are critical for enhanced bacterial opsonization and phagocytosis as well 
as antibody-dependent cellular cytotoxicity (ADCC). Proper development of a Th1 
cell-mediated immune response and production of appropriate antibodies are 
required for the efficient control of primary Salmonella infections. 
1.1.  Classification of Salmonella 
Salmonella are facultative intracellular bacteria that belong to the 
Enterobacteriaceae family, a group that contains other gram-negative, medically 
important bacteria like Shigella and E. coli. The Salmonella’s genus consists of two 
species, S. enterica and S. bongori, the latter being an opportunistic pathogen and 
restricted to cold blooded animals (Euzéby, 1999), making the other genus (S. 
enterica) of most interest in the study of host-parasite interactions. 
S. enterica is divided into six subspecies and is further classified to 
serogroups based on their somatic (O) and flagellar (H) antigens (Costa et al., 2012). 
These subspecies are genetically similar but can be classified according to their host 
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tropism and whether they cause systemic or local infections. S. enterica serovar 
Typhi is a human pathogen that results in systemic infection (typhoid fever) and does 
not naturally, infect any other mammals. S. enterica serovar Typhimurium, causes a 
systemic infection (typhoid like disease) in mice, and a localized gastroenteritis in 
humans (Parry et al., 2002). Other serovars of these subspecies are also host-
restricted, such as S. Dublin in bovine and S. Cholerasuis in swine (Costa et al., 
2012). 
Salmonella-mediated infections have a global impact. In developed nations, 
gastroenteritis caused by Non-Typhoidal Salmonella (NTS) is a major cause of 
mortality due to contaminated food, with food outbreaks having a significant impact 
on the healthcare system and economy of affected countries (Nyachuba, 2010). On 
the other hand, Salmonella has a greater impact on the developing nations of the 
globe. Salmonella Typhi and Paratyphi strains are transmitted from human to human 
due to lack of proper sanitation system and poor hygiene, resulting in systemic 
infections with high mortality rates (Parry et al., 2002). Moreover, in immune-
deficient individuals (such as HIV patients), infections by NTS are associated with 
high death rates due to the rapid and systemic dissemination of the pathogens 
(Feasey et al., 2012). 
1.2. Salmonella pathogenesis 
Studying the pathogenesis of Salmonella requires the availability of an 
animal model that mimics the interactions occurring in humans. S. Typhi and S. 
Paratyphi are both human-restricted serovars that cause a systemic infection, called 
typhoid fever. These serovars are not pathogenic in animals; instead serovar S. 
typimurium is capable of infecting mice, causing an invasive systemic typhoid-like 
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disease, making it the most widely accepted model of  typhoid fever in experimental 
animals (Hormaeche, 1979). 
Salmonella bacteria encode many virulence factors that facilitate their 
efficient invasion in host tissue. Being a water-borne pathogen, the primary mode of 
transmission is through the oral route. After colonizing the lumen of the intestine 
(Fig. 1), the bacteria start producing molecules that are injected to the epithelia lining 
of the mucosa in a needle like projection called type III secretion system (T3SS). 
This invasion machinery is regulated by genes located in a genetic locus called 
Salmonella pathogenicity island 1 (SPI-1). It has been shown that mutations in SPI-1 
render Salmonella non-virulent (Penheiter et al., 1997). Consequent to the invasion, 
Salmonella organisms colonize host macrophages and use them for intracellular 
replication as well as for systemic dissemination to target organs. This phase of 
infection is regulated by a set of proteins encoded on SPI-2 (Salmonella 
pathogenicity island 2) (Salcedo et al., 2001). Upon entry into host macrophages, 
Salmonella organisms are taken up into a phagosome that fuses with the lysosome to 
form a phagolysosome, enabling the lysis of the invading bacteria (Chakravortty et 
al., 2002). Host macrophages also play an important role as antigen-presenting cells, 
displaying Salmonella-derived peptides with MHC class II molecules for recognition 
by CD4
+
 T cells, thereby initiating the adaptive immune response (Mittrücker et al., 
2002). 
In case of Salmonella, induction of the SPI-2 encoded type III secretion 
system prevents the fusion of the lysosome with the phagosome, thus acting as a 
critical virulence factor (Cirillo et al. 1998; Pfeifer et al. 1999). The action of SPI-2-
encoded proteins transforms the phagosome into a hospitable environment, named  
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Salmonella-containing vacuole (SCV), which allows bacterial replication and growth 
(Lefebre & Galán et al., 2014). Recently, another study challenged these earlier 
findings by demonstrating that high bacterial loads can be achieved within 
phagocytic cells by SPI-2 mutant bacterial strains (Grant et al., 2012). Instead, the 
new data favor a model whereby SPI-2 T3SS confers the ability on the bacteria to 
B 
A 
Figure 1: Salmonella pathogenesis. 
 Schematic illustration of the infection of epithelial cells of the lower intestine 
and macrophages by Salmonella is shown (A) Salmonella then translocate across 
M cells of Peyer’s patches or actively invade epithelial cells by the secretion of 
effector proteins through the SPI-1 encoded T3SS-1.(B) (i) After crossing the 
epithelial barrier, Salmonella are engulfed by proximal macrophages that will 
secrete effector proteins into the cytosol of the cell via the SPI-2 encoded T3SS-
2 and prevent fusion of the phagosome with the lysosome. (ii)With in the SCV, 
Salmonella will proliferate resulting in cytokine secretion by the macrophage. 
(iii) Finally, the macrophage will undergo apoptosis, and Salmonella will escape 
the cell to basolaterally reinvade epithelial cells or other phagocytic cells of the 
host innate immune system. (Reference: Hurley et al., 2014). 
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exit the infected macrophage and establish new foci of infection, thereby aiding in 
bacterial dissemination. The induction of SPI-2 effectors during the acute phase of 
the infection is a critical determinant of Salmonella virulence and its capacity to 
spread systemically into deeper host tissues. Salmonella strains carrying mutations in 
SPI-2 fail to cause a systemic infection (Penheiter et al., 1997).  
1.3. Innate immunity to Salmonella infection 
Salmonella infection occurs through the ingestion of contaminated 
food/water, in which Salmonella survive the stomach acidity and colonizes the 
intestine (Muller et al., 2009). Invasion of the intestinal epithelium is facilitated 
through specialized cells called M cells (Microfold cells) which functions by 
sampling the antigenic contents of the gut (Halle et al., 2007)  This process is 
dependent on the SPI-1 which encodes several proteins that are injected through a 
needle-like complex called T3SS (type 3 secretory system). These proteins hijack the 
cell machinery in order to facilitate the bacterial invasion process (Jones et al., 1994; 
Penheiter et al., 1997). Once the bacterium reaches the lymphoid cells in Peyer’s 
patches (PP), it gets engulfed by the phagocytes located there (Hopkins et al., 2000; 
Wick, 2002). Meanwhile, macrophage containing bacteria travel through the body’s 
lymphatic system to the mesenteric lymph node (MLN) and then the bacteria at that 
stage starts spreading systemically to the spleen and liver ( Mittrücker & Kaufmann 
et al., 2000).  
Control of the salmonella infection is mediated by the host’s different 
components of the innate immune system components, which must prevent the 
systemic spread of bacteria (Fig. 2). Early recognition of Salmonella bacteria is 
mediated by the TLRs (Toll like receptors), a family of pattern recognition receptors 
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(PRRs), that recognize conserved components of Salmonella called pathogen 
associated molecular patterns (PAMP). To date, four TLRs have been shown to be 
involved in the response to Salmonella infection, including TLR2, TLR4, TLR5 and 
TLR9 which mediate the recognition of lipoproteins and bacterial amyloid fibers, 
lipopolysaccharide, flagellin, and CpG DNA, respectively (Takeuchi et al., 1999; 
Gewirtz et al., 2001; Feuillet et al., 2006; O'Brien et al., 1980; Vazquez-Torres et al., 
2004; Hayashi et al., 2001; Tükel et al, 2009). Additionally, a different family of 
intracellular receptors, called NOD-like receptors (NLRs), mediates the recognition 
of Salmonella virulence protein products (Miao et al., 2010). Recognition of multiple 
bacterial products via PRRs results in the production of proinflammatory cytokines 
and chemokines, which, in turn, leads to the recruitment of neutrophils and 
monocytes to the site of recognition (intestinal lymphoid tissue). Migration of these 
cells forms an inflammatory foci, and results in increasing the level of TNF-, IL-1 
and nitric oxide that will arrest bacterial spread (Rydström & Wick, 2007). The 
inflammatory foci will lead to the production of other inflammatory cytokines such 
as IL-6, IL-12, IL-18 and IL-23 (Thiennimitr et al., 2012). That will have an impact 
on lymphocytes and NK cells, inducing the production of IFN-. IFN- activates the 
microbicidal activity of the phagocyte-containing bacteria, as well as the activation 
of a CD4
+
 Th1 immune response that contributes to the complete clearance of the 
bacterium, and provides the host with protection against secondary infection through 
the adaptive immune response (Hormaeche et al., 1990). 
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1.4. Animal models for Salmonella infection 
Studying the mechanisms of a particular pathogen requires the availability of 
model that mimics the events occurring in humans. As previously stated, oral 
inoculation of S. typhimurium causes a systemic infection in mice similar to typhoid 
fever in humans, making it a suitable typhoid fever model (Hormaeche, 1979) . The 
genetic makeup of the host is decisive in determining the susceptibility to infection. 
By gene targeting several mouse models have been developed to study the role of 
different genes in Salmonella infection. Using a virulent strain of bacteria in a 
susceptible mouse background, leads to early mortality.  In contrast, the use of 
attenuated strains of Salmonella allows one to dissect the complex interplay between 
Figure 2: Innate immunity to intracellular pathogens. 
A schematic presentation of the innate immune response, CD4
+
 T cell 
differentiation and function of major regulatory cytokines generated in response 
to infection with intracellular pathogens. Effector Th1 CD4
+
 T cells, CD8
+
 T 
cells, and NK cells activate the phagocytes, through IFN-γ production, to kill the 
intracellular microbes via generation of toxic products such as NO and ROIs. 
(Reference: Ismail et al., 2002). 
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pathogen and host. The derivation of Salmonella strains carrying mutations in 
various genes of the metabolic pathway has greatly facilitated work on defining the 
contribution of various host genes in Salmonella infection. The best characterized 
Salmonella mutants have genetic mutations in genes coding for enzymes involved in 
the biosynthetic pathway of aromatic amino acids, such as aminobenzoic acid and 
dihydroxybenzoic acid. As these aromatic compounds are not normally produced in 
mammalian hosts, the use of bacterial strains with these genetic mutations render 
them avirulent (Hoiseth & Stocker 1981). 
1.5. Susceptibility factors to salmonella infection 
Immunity to Salmonella infection requires the synergistic effect of multiple 
components of the immune system. Defects in specific immune system pathways 
increase the host’s susceptibility to Salmonella infection. The use of attenuated 
Salmonella strains and genetically defined animal models have greatly facilitated 
work on dissecting the contribution of different components of the immune system. 
In this section, the role of the most important contributing factors in Salmonella 
infection will be discussed. 
1.5.1. Nramp1 
Studies have identified a gene that controls bacterial replication, as an innate 
resistance trait for Salmonella infection, called Nramp1 gene (Natural resistance 
associated macrophage protein1) (Vidal et al., 1995). The Nramp1 gene encodes a 
transmembrane lysosomal protein that acts as a channel for divalent cations and 
controls intracellular microbial replication during the early phase of infection. The 
Nramp1-associated resistance to infection is due to an almost complete inhibition of 
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early bacterial growth in phagocytic cells (Plant & Glynn, 1979; Gruenheid & Gros, 
2000; Forbes and Gros 2001).  
Nramp1 is considered a resistance factor in Salmonella infection and 
functions at multiple levels to enhance the macrophage killing ability: 1) increases 
response to activating cytokines TNF- and IFN-, 2) enhances antigen processing 
and presentation by increasing the expression of MHC class II molecule to facilitate 
the CD4
+
 T-cell expansion, and 3) increase the early production of IFN- by NK cells 
(Soo et al., 1998). Certain inbred mouse strains, such as C57BL/6 and BALB/c, carry 
a mutated form of the Nramp1 gene and are at least 1000-fold more susceptible to 
infection with S. typhimurium than 129sv and C3H lineage mouse strains that carry 
the wild-type gene allele. Mutations in Nramp1 gene have also been associated with 
increased susceptibility to intracellular infections in humans (Skamene et al. 1998). 
1.5.2. Toll like receptors 
TLRs play an essential role in the innate immune response against Salmonella 
infection. C3H/HeJ mice are well known for their hyporesponsiveness to LPS and for 
being hypersusceptible to Gram-negative bacterial infections (O’Brien et al., 1982). 
The underlying genetic basis of this phenotype was shown to be a mutation in the 
TLR4 gene (Poltorak et al., 1998; Qureshi et al., 1999), which emphasizes the central 
role of LPS recognition by TLR4 in the immune response to Salmonella infection. 
As referred to earlier, other Salmonella PAMPs known to be recognized by TLRs 
include lipoprotein (TLR2), flagellin (TLR5) and CpG DNA (TLR9). Among those 
receptors, TLR4 appears to be the most crucial in immunity to Salmonella due to its 
effect on secreting proinflammatory cytokines upon recognition of Salmonella, 
which leads to macrophage activation and killing of the bacteria by the activation of 
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antimicrobial effectors such as nitric oxide (Weiss et al., 2004) . Despite the fact that 
C3H/HeJ mice harbor a functional Nramp1 gene, infection with an attenuated strain 
of S. typhimurium revealed a defect in controlling the growth of the bacteria when 
compared to mice harboring functional TLR4 gene, supporting the essential role of 
TLR4 in immunity to Salmonella infections ( Al-Ojali et al., 2013). 
1.5.3. MyD88 
Myeloid differentiation protein-88 (MyD88) is an adaptor molecule for 
utilizing the TLR signals upon the recognition of pathogens. MyD88 recruits IL-1 
receptor-associated kinase 4 (IRAK4) and TNF receptor-activated factor 6 (TRAF6), 
which leads to the activation of NF-b, and eventually the expression of 
proinflammatory cytokines and chemokines. It has been shown that MyD88 
deficiency leads to losing the protective immunity to pyogenic bacteria in humans 
and animals (von Bernuth et al., 2008). Furthermore, mice lacking MyD88 are highly 
susceptible to attenuated strain of S. typhimurium due to their inability to control 
systemic bacterial spread and growth in target organs, accompanied with delayed 
recruitment of phagocytic cells, and defective cytokine production (Issac et al., 
2013).  
1.5.4. Cytokines 
Communication between immune cells is accomplished through cytokines 
that act on cells harboring cytokine-specific receptors and causing a particular 
response through the signal transduction machinery. Immunity to Salmonella 
infection requires the collaboration between multiple cytokines to drive the immune 
cells to the proper action and, eventually, control the infection. To date, many studies 
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in the Salmonella model have highlighted critical roles for TNF-, IL-12, IL-18 and 
IFN- in Salmonella immunity. Defects in any of these cytokines or their receptors 
increase the host’s susceptibility to Salmonella infection. 
1.5.4.1. TNF- 
Tumor necrosis factor alpha (TNF-) is an inflammatory cytokine that has an 
essential role in controlling infection of different pathogens (Mastroeni et al., 1992; 
Green et al., 1993). It is associated with the recruitment of mononuclear cells and 
induction of nitric oxide that lead to bacterial killing (Havell, 1989; Mastroeni et al., 
1995). TNF- works synergistically with IFN- to enhance the bactericidal activity 
of macrophages (Tite et al., 1991). A previous study has shown that mice with 
defects in TNF- receptor expression have heightened susceptibility to virulent as 
well as avirulent strains of S. typhimurium in an oral infection model (Everest et al., 
1998). Interestingly, these mice appeared to be less prone to infection-related 
mortality by attenuated aroA
-
 Salmonella mutants in comparison with mice deficient 
in IFN- (Hess et al., 1996).  
Another study investigated the precise role of TNF- in macrophage 
phagocytic and anti-Salmonella microbicidal activity (Vázquez-Torres et al., 2001) 
and demonstrated that TNFRp55-deficient macrophages are unable to localize 
NADPH oxidase-containing vesicles to Salmonella-containing vacuoles, resulting in 
increased susceptibility to infection. 
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1.5.4.2. IL-12 
Interleukin 12 (IL-12) is a heterodimeric cytokine produced primarily by  
macrophages, polymorphonuclear cells and dendritic cells following engagement of 
PRRs by PAMPs (Brunda, 1994). IL-12 mediates immunity to Salmonella through 
the induction of IFN- production by NK cells and T cells, and facilitates the 
development of a Th1 response (Castro et al., 1995; Manetti et al., 1993). Resistance 
to many intracellular pathogens, such as Leishmania, Mycobacterium and Brucella, 
is mediated by IL-12 (Locksley, 1993; Cooper et al., 1995; Heinzel et al., 1995; Zhan 
& Cheers, 1995). 
In innately resistance A/J mice (normal Nramp1
n
), neutralization of IL-12 via 
monoclonal antibodies, impaired the control of bacterial proliferation at late stage of 
infection with virulent S. Typhimurium C5 strain. This effect correlated with a 
significant decrease in IFN- levels in serum and spleen when compared with non-
treated infected mice (Mastroeni et al., 1996).  
Neutralization of IL-12 in susceptible BALB/c mice (mutated Nramp1
d
 gene) 
exacerbated infection with an attenuated aroA-deficient strain of S. typhimurium, 
with a significant increase in the bacterial burden in the spleen and liver 100-fold 
more than non-treated infected BALB/c. The increased susceptibility was mediated 
through a reduction in IFN- and downregulation of the expression of MHC class II 
and iNOS, important indicators of deficient macrophage activation. Treatment of 
these mice with recombinant IFN- restored their host resistance, reduced bacterial 
burden in spleen and liver, up-regulated MHC class II in macrophages and decreased 
the level of IL-10 which was elevated when treated with anti-IL-12. The results from 
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this study demonstrate the protective role of IL-12 in host defense against Salmonella 
infection, which is mediated by IFN- (Mastroeni et al., 1998).  
1.5.4.3. IL-18 
Interleukin-18 (IL-18) is a cytokine produced by several cell types in 
response to bacterial and inflammatory stimuli (Stoll et al., 1997). IL-18 works 
synergistically with IL-12 to promote the production of IFN- from T-cells, in part 
by IL-12-mediated induction of IL-18 receptor expression (Takeda et al., 1998). This 
cytokine plays an important role in defense against Salmonella bacteria, as 
neutralization using monoclonal antibodies lead to an increase in bacterial load in 
spleen and liver, coinciding with low IFN- levels in serum. Treatment of these mice 
with recombinant IL-18, reversed the neutralization effect and increased mice 
survival and IFN- production (Mastroeni et al., 1999). Finally, IL-18 is dependent 
on the availability of IL-12 in order to induce IFN-production, which was 
confirmed by failure of treating infected IL-12p40 knockout mice with recombinant 
IL-18, to increase the production of IFN- necessary for enhancing the survival of 
these mice (Dybing et al., 1999).   
1.5.4.4. IFN- 
Interferons were first discovered as physiologic agents that interfere with 
viral replication (Isaacs & Lindenmann, 1957). They are classified into type I 
(consisting of IFN IFNIFN and IFNand type II which only consist of 
IFN IFNis structurally unrelated to type I interferons, and binds to a specific 
receptor composed of two subunits (IFN-R1 and IFN-R2).  
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Signaling through the IFN- receptor is mediated by JAK1 and JAK2, two 
Janus tyrosine Kinases that transmit the signal through phosphorylation of STAT1 
(signal transducer and activator of transcription) (Schindler et al., 2007). 
Phosphorylation of STAT1 allows dimerization of the molecule allowing it to 
translocate to the nucleus and act as a transcription factor responsible for the up-
regulation of many IFN- regulated genes (Bach et al., 1997). 
IFN- is produced in response to a microbial encounter in a temporal fashion. 
Depending on the phase of the immune response, two cell types are primarily 
responsible for IFN- production. NK cells are the main producers during the early 
innate phase of the immune response and CD4
+
 Th1 cells during the adaptive 
immune response phase. The whole process begins by the recognition of a pathogen 
associated molecular pattern (PAMP), such as lipopolysaccharide (LPS), by a pattern 
recognition receptor (PRR) on macrophages and dendritic cells. This engagement 
triggers a cascade of downstream signaling pathway, which is crucially dependent on 
the adaptor molecule MyD88 (Myeloid Differentiation 88), ultimately leading to the 
activation of the transcription factor NF-b.  As a master regulator, NF-b activates 
gene transcription of many proinflammatory cytokines, including IL-1, IL-6, IL-12, 
IL-18 and TNF-. IL-12 plays a critical dual role in activating NK cells to produce 
IFN- and induces the differentiation of CD4+ T cells to the Th1 pathway (Xie et al., 
1997; Schwacha et al., 1998). The secreted IFN-, in turn, binds to its high-affinity 
receptors on macrophages leading to increased macrophage microbicidal activity 
and, hence, elimination of the invading pathogen (Mastroeni et al., 1998; Mastroeni 
et al., 1999; Pie et al., 1997). 
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1.6. Adaptive immunity to Salmonella infection  
Controlling Salmonella infection at early stages is maintained by the innate 
immune system. However, achieving full protection and complete eradication of 
Salmonella at later stages of infection requires the development of a Salmonella-
specific T cell response.  
In primary infections with attenuated Salmonella strains in susceptible mice, 
CD4
+
 TCR+ T cells with a Th1 phenotype mediate the clearance of the bacteria 
from the tissues with little or no obvious contribution of CD8
+
 T cells (Hess et al., 
1996). B cells are dispensable in primary infection with similar attenuated 
Salmonella strains, as mice lacking B cells were able to resolve infection with similar 
kinetics to wild type mice (Mcsorley et al., 2000; Mastroeni et al., 2000). 
On the other hand, resistance to virulent challenge in susceptible mice 
requires the action of both CD4
+
 and CD8
+
 T cells with the additional requirement 
for anti-Salmonella antibodies (Mastroeni et al., 1992; Mastroeni et al., 1993). In 
these studies, depletion of CD4
+
 or CD8
+
 T cells in mice immunized with attenuated 
Salmonella strain, leads to the death of mice after challenge with virulent strain of 
Salmonella (Mastroeni et al., 1992), and the adoptive transfer of spleen cells alone 
from immunized to naïve mice was not sufficient for conferring protection against 
virulent Salmonella infection (Mastroeni et al., 1993). However, the transfer of 
spleen cells and serum was shown to provide immunity against challenge with 
virulent Salmonella infection (Mastroeni et al., 1993).  
CD4
+
 T cells contribute to protection via the production of Th1 cytokines 
such as IFN-and TNF-that leads to the activation of macrophages containing 
Salmonella (Ravindran et al., 2005). Depletion of Th1 cytokines (IFN-, TNF- and 
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IL-12) impaired the protection of immunized mice after secondary infection with 
Salmonella ((Mastroeni et al., 1998; Mastroeni et al., 1992). 
 CD8
+
 T cells are important for host defense against intracellular pathogens 
(Kaufmann et al., 1995). They kill Salmonella-infected host target cells via the 
release of cytotoxins (perforin 1 and granzymes), creating holes in the target-cells 
membrane (Harty & Bevan, 1999).  
B cells have an essential role in providing protection against virulent 
Salmonella infection, since B cells-deficient mice challenged orally with virulent 
Salmonella after vaccination, failed to control the infection (Mastroeni et al., 2000). 
In addition, B cells also confer protection through its contribution in the expansion of 
anti-Salmonella Th1 cells. This was observed in a study, where total splenocytes  and 
purified CD4
+
 T cells isolated from Igh-6
-/-
 (B cell deficient) mice after vaccination 
showed an impaired production of Th1 cytokines after stimulation in vitro with 
Salmonella antigens (Ugrinovic et al., 2003). 
  
1.7. Role of IFN- in immunity to Salmonella 
IFN- is a decisive factor in immunity to Salmonella infection. The essential 
function of IFN- is to activate macrophages and yield a protective response by 
enhancing antigen presentation, and skewing the T-cells towards a protective Th1 
response (Shtrichman & Samuel, 2001). In innately resistant mice, depletion of IFN-
 with mAbs resulted in the loss of resistance to a virulent strain of S. typhimurium, 
and mice succumb to infection at early stage of infection (7 days), in comparison to 
the non-treated infected mice where they remained alive through the infection course 
(Nauciel & Espinasse-Maes, 1992). In susceptible C57BL/6 mice (mutated Nramp1), 
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oral infection with attenuated aroA
-
/aroD
-
 mutants S. typhimurium, resulted in a 
controlled infection with all mice surviving the infection. This was attributed 
primarily to IFN-, as infecting IFN--deficient mice with same bacterial dose 
rendered them susceptible to an attenuated strain of Salmonella. This susceptibility 
was marked with increased bacterial growth over time seen as lesions in liver, spleen, 
mesenteric lymph node and PP, as compared to a controlled bacterial growth in wild 
type mice. Histological analysis, showed a decrease in the cells expressing MHC 
class II, suggesting a defect in macrophage activation (Bao et al., 2000). This IFN- 
dependent expression of MHC class II was observed in another study where Bacillus 
Calmette Guerin (BCG) infection in IFN- knockout mice, also showed susceptibility 
related to the lack of macrophage activation, impaired nitric oxide production and 
reduced MHC class II expression (Dalton et al., 1993).  
1.8. Role of IFN- in Salmonella persistence 
In human Salmonella infection, about (1-6%) of the patients become chronic 
carriers, with bacteria remaining in these patients without causing any symptoms, but 
showing a continuous bacterial shedding in stool and urine for a long period of time 
that ranged from 1 year to lifetime (Levine et al., 1982). This occurs despite evidence 
of adequate immune responses in these carriers, including high levels of serum 
antibodies against the pathogen (House et al., 2001). A similar phenomenon was 
observed in inherently-resistant mice, such as strain 129sv with functional Nramp1, 
infected orally with virulent S. typhimurium (strain SL1344). In this model, mice 
were infected and monitored for up to one year for bacterial shedding in the feces 
(Monack et al., 2004). The findings showed that infection resulted in bacterial 
persistence and fecal shedding throughout the study period. This occurred despite 
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evidence of high levels of anti-Salmonella antibodies being present in infected mice. 
Examination of the systemic colonization of bacteria over the 1-year period 
identified the mesenteric lymph nodes as the site where bacteria persisted. Since 
many studies have shown the role of IFN- in maintaining the early phase of 
Salmonella infection (Nauciel & Espinasse-Maes, 1992), the role of IFN- in 
Salmonella persistence was studied. Depletion of IFN- in chronically infected mice 
(260 days post infection) by a 3-week treatment with a neutralizing mAb led to the 
systemic spread of bacteria to different organs. This confirmed the primary role of 
IFN- in maintaining the balance between the immune system and bacteria, by 
suppressing bacterial replication in infected macrophages (Monack et al., 2004). 
 
1.9. Recombinant attenuated Salmonella  
Attenuated strains of Salmonella had been greatly used in humans as vector 
encoded vaccines for a variety of non-Salmonella pathogens. This effect was 
attributed to invasive characteristics of Salmonella that elucidate B and T cell 
memory response with long lasting immunity (Roland & Brenneman, 2013).  
Attenuated Salmonella strains have been used for vaccine delivery through cloning 
genes encoding heterologous protective antigens, and then the Salmonella express 
that antigen through a stable Inducible promoter. Attenuated Salmonella has been 
used in one study as a vaccine for Leishmania major parasite, where attenuated 
Salmonella expressing GP63 afforded protection to susceptible BALB/c mice after 
oral challenge with virulent Leishmania. This protection was developed through a 
Th1 response and yielded a high levels of Leishmania-specific antibodies (Xu et al., 
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1995). Other studies have used attenuated Salmonella engineered to express 
heterologous proteins of other pathogens, including viruses, bacteria and fungi. 
These strains were able to achieve specific immune response and render protection 
upon challenge with virulent pathogen (Pasetti et al., 2003).  
1.10.  Attenuated Salmonella expressing cytokines 
The use of attenuated Salmonella as vaccine is effective when the 
circumstances of achieving a specific immune response towards the vaccine are met. 
The fate of such vaccine requires the availability of a healthy immune response. 
However, using an attenuated vaccine in immunocompromized hosts could lead to 
systemic, lethal, infections. An attenuated strain of Salmonella engineered to express 
a particular cytokine is one way of guiding the immune response of 
immunocompromized hosts to achieve the required protection.  
This was first done with the construction of an attenuated strain of 
Salmonella that expressed the human IL-1 cytokine. The resultant strain was able to 
cause an immunological reaction influenced by the expressed cytokine, shown by the 
high levels of antibodies against the engineered human IL-1 (Carrier et al., 1992). 
This was followed by the construction of attenuated Salmonella strains 
expressing murine cytokines, including IL-2, TNF-, IFN- and MIF (Xu et al., 
1998). These strains were used to boost the immunity of susceptible BALB/c mice 
against Leishmania major infection through the induction of protective Th1 
responses (Xu et al., 1998). The potential of these cytokine-expressing strains in 
regulating anti-Salmonella immune responses in susceptible BALB/c mice was also 
explored (al-Ramadi et al., 2001; al-Ramadi et al., 2002). Salmonella strains 
expressing IL-2 or TNF-, designated GIDIL2 and GIDTNF respectively, were 
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compared with parental non cytokine-expressing Salmonella strain, designated 
BRD509E, in terms of their influence on the anti-Salmonella immune response. The 
findings demonstrated that the expression of IL-2 by the GIDIL2 strain led to a rapid 
clearance of bacteria with decreased splenomegaly and enhanced macrophage 
activation through the upregulation of cell surface proteins and induction of high 
levels of nitric oxide synthesis. GIDIL2-vaccinated mice also developed high levels 
of resistance to subsequent challenge with the virulent SL1344 Salmonella strain (al-
Ramadi et al., 2001; al-Ramadi et al., 2002). 
Subsequent studies focused on analyzing the effect of infection with 
cytokine-expressing strains in immunodeficient mice with the aim of delivering 
compensatory tools for different immunodeficient mouse model. Given the essential 
role of IFN- in immunity against Salmonella, an attenuated strain of Salmonella was 
engineered to express murine IFN-, designated GIDIFN (Xu et al., 1998). In vitro 
studies have shown the ability of GIDIFN to induce a strong immune response 
demonstrated by the production of TNF-, IL-6, IL-12p40 and NO, with specific 
targeting of macrophages leading to the upregulation of several activation markers 
and surface costimulatory molecules. These effects were much more pronounced 
than with the use of GIDIL2 or the parental, non-cytokine-expressing, BRD509E 
strain (Fernandez-Cabezudo et al., 2009). Furthermore, the potential of GIDIFN was 
tested in vivo in different immunocompromized murine models. GIDIFN was able to 
confer a protective response to mice with a deficiency in TLR4, an essential 
molecule for the recognition of LPS component of the bacteria (Al-Ojali et al., 
2013). This effect correlated with a more efficient control of bacterial proliferation in 
systemic target organs, presumably through the increased production of 
proinflammatory cytokines IL-6 and IL-12 (Al-Ojali et al., 2013). Vaccination of 
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these susceptible mice with GIDIFN also provided protection against challenge with 
virulent Salmonella that was significantly higher than in mice immunized with 
BRD509 (Al-Ojali et al., 2013). GIDIFN was also able to enhance the anti-bacterial 
response in mice deficient in CD154 protein, an essential molecule for induction of 
type 1 cytokines and antibody isotype switching response (al-Ramadi et al., 2006; 
Al-Ojali et al., 2012). This was demonstrated by reduced bacterial load in target 
organs and increased mouse survival, which was mechanistically linked with an 
enhanced proinflammatory cytokine response, including IL-6, IL-12, TNF- and 
IFN- (Al-Ojali et al., 2012). In addition, GIDIFN was able to afford protection to 
CD154
-/-
 mice when challenged with lethal Salmonella (Al-Ojali et al., 2012). 
A previous study demonstrated that mice deficient in IFN- regained their 
resistance after injecting them with recombinant IFN- (Mastroeni et al., 1998). So 
we hypothesized that it might be possible to compensate for the deficiency of IFN- 
in IFN- mice through the use of the GIDIFN Salmonella strain. This is the 
premise on which the studies conducted in this project were carried out. 
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Chapter 2: Materials and Methods 
 
2.1 Materials 
2.1.1. Summary of materials used and suppliers   
Materials Company 
SS Agar Mast Group 
Ampicillin Sigma 
Streptomycin Sigma 
Microscopic slides Fischer Scientific 
7-AAD Viability Staining Solution e-Bioscience 
PBS (-CaCL2 – MgCl2 ) GIBCO 
BSA Sigma 
RPMI 1640 medium (-L glutamine) HyClone 
Ethanol Carlo Erba 
H2SO4 Readel-de Haen 
Trypan blue solution (0.4%) Sigma 
Thioglycolate Sigma-Aldrich 
Trypticase soy broth Oxoid 
24 well tissue culture plates Becton Dickenson 
96 well Microtest U bottom culture 
plates 
Becton Dickenson 
96 well Maxisorp Nunc Immuno plate Thermo Scientific 
                                                                                                                                                            
Table 1: Summary of materials used and supplies 
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2.1.2. Summary of antibodies used 
Antibody Conjugate Company Catalogue Dilution 
used 
Armenian 
hamster anti-
mouse CD3 
FITC e-Bioscience 11-0031-85 1:100 
Rat anti-mouse 
CD11b 
APC-
eFluor780 
e-Bioscience 47-0112-82 1:500 
Rat anti-mouse 
CD19 
PE-cy7 BD Pharmingen 552854 1:200 
Rat anti-mouse 
Gr-1 
PE BD Pharmingen 553128 1:500 
Armenian 
Hamster IgG1 
Isotype Control 
Alexa 
Fluor488 
e-Bioscience 12488883 1:200 
Rat IgG2b,k 
Isotype Control 
APC-
eFluor780 
e-Bioscience 47-4031-82 1:200 
Rat IgG2a,k 
Isotype Control 
 
PE-cy7 e-Bioscience 25-4321-82 1:200 
Rat IgG2b,k 
Isotype Control 
 
PE e-Bioscience 12-4031-82 1:200 
Anti-mouse 
CD16/CD32  
- e-Bioscience 14-0161-85 1:100 
                                                                                                                                
Table 2: Summary of antibodies used 
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2.1.3. List of primers used for RT-PCR 
 
Table 3: Summary of primers used for RT-PCR 
2.1.4. Mice 
C57BL/6 mice were purchased from Harlan Olac (Bicester, UK). All strains 
were bred at the animal facility in the College of Medicine and Health Sciences, 
UAE University and used at 8–12 weeks of age. Mice received rodent chow and 
water ad libitum. All studies involving animals were carried out in accordance with, 
and after approval of, the animal research ethics committee of the College of 
Medicine and Health Sciences, UAE University. 
2.2. Methods 
2.2.1. Bacterial strains and growth condtions 
BRD509E is an attenuated, aroA
−
/aroD
−
 mutant strain derived from SL1344 
with an LD50 of 5 x10
6 
CFUs per mouse when administered i.p. to susceptible mice. 
For the current study, a derivative of BRD509E expressing the empty nirB plasmid 
vector, which was developed in al-Ramadi laboratory, was used. The latter strain 
Gene Source Assay I.D Reporter 
dye 
Quencher 
HPRT Applied biosystem Mm01545399-ml FAM NFQ 
iNOS Applied biosystem Mm00440502-m1 FAM NFQ 
S100A9 Applied biosystem Mm00656925-m1 FAM NFQ 
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behaves indistinguishably from BRD509E except for the fact that it acquired 
resistance to ampicllin, which is encoded by the nirB plasmid, and can, therefore, be 
easily selected, transfectant of the BRD509E strain, designated GIDIFN, in which 
the murine IFN- gene is expressed, was also used. The expression of IFN- is under 
the control of the anaerobic growth-induced nirB promoter, and cytokine expression 
was maintained by selection in 100 μg/ml ampicilin. 
Aliquots of frozen bacteria were routinely plated on Salmonella Shigella 
(S.S) agar (Oxoid, Basingstoke, United Kingdom) in the presence of ampicillin and 
grown overnight at 37°C. Five to ten CFUs were cultured overnight in Trypticase 
Soy broth and then diluted 1:10 in fresh medium and grown for a further 2-3 hr at 37 
°C with shaking. For induction of cytokine expression, bacterial colonies of the 
GIDIFN strain were grown under anaerobic conditions overnight at 37°C in T-Soy 
broth containing ampicillin and 4 mg/ml glucose in a closed screw-cap container. 
The concentration of bacterial suspensions was estimated from spectrophotometer 
readings at 600nm wavelength using the following formula:  
OD600 of 0.1 =1.2x10
8 
CFUs/ml 
Appropriate dilutions of log-phase bacterial suspensions were prepared in 
pyrogen-free phosphorus-buffered saline (PBS) (Sigma Chemical Co., St. Louis, 
Mo.) and administered i.p. in 0.5 ml volume per mouse. Bacterial doses were 
confirmed by CFU plate counts.  
2.2.2. Enumeration of bacteria in organ homogenates 
To determine liver bacterial load, the organs were removed aseptically, 
individually weighed and homogenized in 1 ml of cold sterile saline in an Ultra-
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terrax T25 tissue homogeniser (Janke and Kunkle, Staufenim Breisgau, Germany). A 
100 μl aliquot of the homogenate, or an appropriate dilution, was plated on SS agar 
plates in the presence or absence of ampicillin, and viable CFUs were determined 
after an overnight incubation. 
2.2.3. Peritoneal cells preparation 
Thioglycolate (4%) was injected to groups of mice 3 days before processing 
day. After sacrificing mouse,10 ml of cold Ca
2+
, Mg
2+ 
free physiological saline was 
injected into the exposed peritoneal cavity. Peritoneal fluid obtained from individual 
mice was withdrawn through the anterior abdominal wall with a 20-gauge needle. 
Then cells were spun down at 1200 rpm for 5 minutes at 4
o
C. Cells were counted on 
a hemocytometer and cell viability was determined by trypan blue dye. 
2.2.4. Spleen cell preparation 
Single cell suspensions were prepared by gently teasing the spleen between 
frosted ends of microscope slides. Cells were spun down at 1200rpm for 5 minutes at 
4
o
C. The spleen cell suspension was depleted of red blood cells by incubation in 
RBC lysis buffer (8.3NH4Cl, 1g KHCO3 1.3ml of 5%EDTA dissolved in 1L distilled 
water) (4 ml/spleen + 6 ml of PBS) for 5 minutes, after which they were spun down 
at 1200 rpm for 5 minutes and suspended in 1xPBS. Cells were counted on a 
hemocytometer and cell viability was determined by trypan blue dye. 
2.2.5. Peritoneal cell culture 
Peritoneal cells from thioglycolate-injected mice were harvested and pooled 
from several similarly-treated mice per group. Cells were seeded in 24-well plates 
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(2x10
6
 cells/well) in 5% antibiotic-free RPMI medium and incubated for 2 hours at 
37
o
C. Log phase BRD509 or GIDIFN were prepared at different MOIs. Cells were 
incubated with bacteria for 1 hour to allow bacterial invasion, after which cells were 
treated with 200 g/ml of gentamicin for 30 minutes to kill all remaining 
extracellular bacteria. Then medium was replaced with a fresh medium containing 20 
g/ml of gentamicin, and cells were incubated for 4 hours, and cell-free supernatants 
were collected and kept at -20°C. Trizol (0.5 ml) was added to the cells in each well 
collected and stored at -80°C for RNA extraction. 
2.2.6. Nitric oxide determination 
Production of NO was measured by the accumulation of NO2
-
 in culture 
supernatants using the Griess reaction. Cells were cultured under the indicated 
conditions for 4 hours and then cell-free culture supernatants were collected and 
frozen at -20°C until analysed. Nitrite content was determined by mixing 50µl of 
culture supernatant with an equal volume of Griess reagent (0.05% N-1-
napthylethylenediamide hydrochloride, 0.5% sulphanilamide in 2.5 % phosphoric 
acid) and incubated at room temperature for 5 to 10 minutes. Nitrite concentration 
was quantified using NaNO2 as the standard and expressed as the micromolar 
concentration of NO2
-
 per 2×10
6
 PECs after 4 hours of incubation. The absorbance at 
562 nm was measured in an automated microplate reader.  
2.2.7. Flow cytometry 
Spleen or peritoneal cell suspensions were prepared from normal or infected 
mice. Cells were re-suspended in staining buffer (PBS/1% FCS/0.1% NaN3) at a 
concentration of 0.5 x 10
6
 cells/well in U-bottom 96-well plate (BD) and incubated 
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with 50 l/well of anti-mouse CD16/CD32-specific mAB (clone 2.4G2) for 30 
minutes at 4
o
C to block FcRIII/II sites in order to avoid nonspecific binding. The 
plate was then centrifuged at 750 rpm for 3 minutes at 4
o
C. After decanting the 
buffer, cells were stained with appropriate dilutions, as mentioned in directly 
conjugated monoclonal antibodies (mAbs; all purchased from eBioscience or BD or 
Biolegend) in a total volume of 100 l/well and analyzed by 6-color FACS. In all 
staining groups, 7-AAD dye (eBioscience) was included in order to exclude non-
viable cells from the analysis. All antibodies were pre-titrated in preliminary 
experiments and used at saturating concentrations. Cells were incubated with a 
mixture of appropriately diluted mAbs at 4
o
C for 30 minutes followed by two wash 
cycles with staining buffer. The first wash was with 100 l/well of staining buffer 
where the cells were mixed well with the pipette and centrifuged. In the second 
wash, 200l/well of staining buffer was added and mixed well followed by 
centrifugation. Cells were finally re-suspended in 200 l/well of staining buffer. Data 
was collected on 30,000 cells using BD FACSCantoII and analyzed by BD 
FACSDiva software. Gating strategies is shown in Fig.3. First, we exclude dead cells 
by gating on the 7AAD negative cells (P2 gate) (Fig.3 A). Then, we analyzed the 
immunophenotype of these viable cells based on the expression of different cell 
markers (Fig.3 B). 
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2.2.8. RNA extraction using Trizol 
RNA was extracted from peritoneal cells by the Trizol method. Cells  (2-5 x 
10
6
 per sample) were pelleted and re-suspended in 1 ml Trizol (Invitrogen) following 
which 200l of chlorophorm was added and mixed well. Once cells were spun down 
at 14000 rpm for 10 minutes, 3 phases are obtained from which the top clear RNA 
layer (~500l) was transferred to a new tube. Equal volume of 2-propanol (~500l) 
was then added and mixed well to precipitate the RNA. Tubes were spun again, 
supernatant was discarded and 500l of 70% ethanol added. On flicking the tubes, 
RNA was observed as a white pellet. Tubes were spun again, supernatant removed 
Figure 3: Flow cytometric analysis gating strategies. 
Illustration of the gating strategies for flow cytometric analysis. (A) Dot plot 
showing SSC vs. 7AAD staining. Gate P2 indicates viable (7AAD-negative) cells. 
(B) Immunophenotyping of viable PECs based on the expression of different cell 
surface markers (CD11b, Gr-1, and CD19). 
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and RNA was finally suspended in 20-40l nuclease free water and stored in -800C. 
The quality and quantity of RNA was determined using the Nanodrop ND-1000 
spectrophotometer (Thermo Scientific, Waltham, MA). 
2.2.9. Reverse Transcription Reaction 
RNA was reverse transcribed using TaqMan reverse transcription reagent 
(Applied Biosystem #N8080234). Each master mix reaction contained 10x RT 
buffer, 25mM MgCl2, deoxy NTPs mixture (2.5mM), random hexamers 
(50RNAase inhibitor (20U/l) and MultiScribe RT enzyme. The master mix 
was aliquoted into separate PCR tubes. RNA was added (1g/10l per reaction) and 
total volume was made up to 50l with nuclease-free water. The one step RT-PCR 
reaction was on GeneAmp PCR System 2700 (Applied Biosystem), under the 
following conditions: hexamer incubation for 10 minutes at 25
0
C, reverse 
transcription at 48
0
C for 30 minutes and reverse transcription inactivation at 95
0
C for 
5 minutes. The samples were held at 4
0
C for a maximum for 1 hour until the sample 
could be removed and stored at –200C. 
2.2.10. Real time PCR reactions 
The real time PCR was performed using TaqMan gene expression assay as 
specified below and amplified using the 7500 Real Time PCR System (Applied 
Biosystems). Each 20l PCR reaction contained 10l of 2xTaqMan Universal 
Master Mix (Applied Biosystems #4440047), 1l of 20x TaqMan assays Mix 
(Applied Biosystems #4331182), 2l cDNA and 7l nuclease-free water. A 
negative PCR reaction was also carried out using only the reaction mixture without 
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cDNA in order to ensure that there was no DNA contamination. The thermal cycling 
conditions were as follows: 95
0
C for 10 minutes (Inactivation of Reverse 
Transcriptase and activation of TaqMan polymerase), 95
0
C for 15 seconds 
(denaturation of dsDNA) and 60
0
C for 1 minute (annealing/extension-fluorescent 
data collected during this step) for a total of 40 cycles with the threshold set as 0.2. 
Data was analyzed using the Ct values for each sample that were in duplicates. 
Results were normalized to HRPT (Hypoxanthine-guanine phosphoribosyl 
transferase) and the mRNA fold change was determined using the following 
equation: 
Fold change= 2[
Ct (infected)
]/2[
Ct (control)
],  
where Ct (infected) = threshold cycle (Ct) for target gene after infection – Ct for 
HPRT after infection and Ct(control) = Ct for target gene saline treated – Ct for 
HPRT saline treated.  
The control used was uninfected wild-type (C57BL/6).  
 2.2.11. Statistical Analysis 
Statistical significance was analyzed using Student's unpaired t-test, Mann-
whitney test, or one way ANOVA with Tukey’s multiple comparison test using the 
statistical program of GraphPad Prism software (San Diego, CA). Differences 
between experimental groups were considered significant when p values were <0.05. 
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Chapter 3: Results 
3.1. Susceptibility to infection by attenuated Salmonella  
Differential susceptibility of immunodeficient mice to Salmonella infection 
normally involves an intricate interplay between cells as well as soluble factors of the 
innate and adaptive immune systems (al-Ramadi et al., 2006). Given the facultative 
intracellular growth nature of the pathogen, macrophages and Th1 lymphocytes play 
critical roles in host protection. One of the most important Th1-produced cytokines 
for macrophage activation is IFN-. Importantly, this proinflammatory cytokine 
upregulates anti-microbial (microbicidal) activity of host macrophages through 
induction of different effectors, such as ROS and NO. Moreover, the induction of the 
T lymphocyte differentiation pathway towards Th1 cells is dependent on IL-12, a 
product secreted primarily by macrophages following stimulation by microbial 
ligands through TLRs. Most TLR signaling pathways depend on MyD88 adaptor 
protein for functionality, hence this molecule’s central importance in innate immune 
responses. It is clear, therefore, that both innate and adaptive immune systems 
cooperate in the response to Salmonella infection. 
To assess the importance of various components of the immune system in 
Salmonella infection, two genetically modified mouse strains were used; the first 
with a deficiency in MyD88 expression, referred to as MyD88
-/-
 (Adachi et al., 1998) 
and the second carrying a deficiency in IFN- synthesis, IFN-/-. Using an attenuated, 
double auxotrophic, strain of S. typhimurium, designated BRD509E (al-Ramadi et 
al., 2001; al-Ramadi et al., 2004), we compared the course of infection in wild type 
control (C57BL/6 mice) and the two immunodeficient mouse strains. The LD50 of 
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BRD509E in wild-type mice is >2x10
6
/mouse when given i.p. (al-Ramadi et al., 
2006). For the current study, the bacterial dose used for infection ranged from 300 to 
1000 CFUs per mouse and the host survival data for the three mouse strains is 
illustrated in Figure 4. As expected, no infection-related mortality was observed in 
C57BL/6 mice. However, MyD88
-/-
 mice infected with BRD509E exhibited an 
overall survival of 35% over the 60-day observation period. This suggests that the 
LD50 dose is <1 x 10
3
 per mouse, representing ~2000-fold increase in susceptibility 
to infection compared to wild-type mice. A similar dose BRD509E inoculation in 
IFN-/- mice was associated with a significantly higher mortality with 100% of the 
mice succumbing to infection by day 28 (p < 0.0001). Median survival of BRD509-
infected MyD88
-/-
 and IFN-/- mice was 51 days and 19.5 days, respectively  (Fig. 4). 
Next, we assessed the differential susceptibility of MyD88
-/-
 and IFN-/- mice 
to infection by a genetically-engineered transfectant of BRD509 in which murine 
IFN- is expressed under the control of a prokaryotic promoter (strain GIDIFN) (Xu, 
et al. 1998). Using a similar dose to BRD509E (verified dose was 300 CFUs/animal), 
infection with the GIDIFN strain resulted in markedly decreased mortality in both 
immunodeficient mouse strains (Fig. 4). For MyD88
-/-
 mice, 90% of animals 
survived the infection with GIDIFN in contrast to the 35% of mice that survived after 
BRD509 inoculation (p = 0.0003). In further studies, increasing the dose of GIDIFN 
to 1x10
5
 CFUs/mouse led to 60% overall survival (Al-Ojali S. and al-Ramadi BK, 
unpublished data), suggesting that the LD50 for GIDIFN in MyD88
-/-
 mice was 
>1x10
5
 CFUs/mouse, which represents >300-fold increase in resistance to infection 
compared to the BRD509E Salmonella strain. 
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An essentially similar picture emerged when IFN-/- mice were infected with 
the GIDIFN bacterial strain (Fig. 4). The right-sided shift observed in the survival 
curve signifies decreased mortality in GIDIFN-infected mice in comparison to those 
infected with BRD509E (p <0.0001). Despite the increase in mean survival from 
19.5 to 26.5 days in animals injected with GIDIFN, the level of resistance to 
Salmonella infection did not match what was observed in similarly treated MyD88
-/-
 
mice. It is therefore clear that notwithstanding the fact that IFN-/- mice are 
significantly more susceptible to Salmonella infection than MyD88
-/-
 mice, infection 
with a strain of bacteria expressing the immunoregulatory cytokine IFN led to a 
marked decrease in the level of susceptibility to Salmonella infection.  
 
 
 
 
Figure 4: Relative survival of WT vs. MyD88-/- vs. IFN-/- deficient mice 
following infection with BRD509E or GIDIFN Salmonella strain. 
WT and MyD88
-/- 
were infected with 10
3
 CFUs/mouse, while IFN-/- were infected 
with 300 CFUs/mouse. Survival was scored for up to 60 days after inoculation. 
Asterisks denote statistically significant differences between BRD509E and 
GIDIFN-infected mice (*p ≤0.05, **p ≤0.01, ***p ≤0.0001). The results are 
representative of 6 independent experiments. 
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3.2. Bacterial loads in systemic organs 
We next assessed the extent of bacterial loads in target organs in different 
strains of mice following infection with BRD509E or GIDIFN. The data for MyD88
-
/-
 vs. WT mice comparison is shown in Figure 5. Infection with either BRD509 or 
GIDIFN strain resulted in similar bacterial growth kinetics in the target organs (liver 
and spleen) in both WT and MyD88
-/-
 mice, except for the significantly lower 
GIDIFN loads observed at all-time points. In WT mice, the number of GIDIFN 
CFUs was 3x and 9.5x fold lower than BRD509E at days 7 and 14 post infection 
(Fig. 5A-B). Strikingly, bacterial loads in MyD88
-/-
 mice were significantly increased 
compared to their wild-type counterparts (Fig. 5C-D). As early as day 3 post 
infection, the bacterial load, of either strain, recovered from MyD88
-/-
 spleens or 
livers was >7-fold or ~17-fold higher than that seen in infected wild-type mice.  The 
significant increase in bacterial proliferation in MyD88
-/-
 mice so early after infection 
suggests that a defective early innate immune response may be responsible. By day 
14 post infection, the bacterial CFUs of the BRD509E strain in MyD88
-/-
 mice 
reached septic levels, with approximately 1 x 10
8
 CFUs/spleen and more than 2 x 10
7
 
CFUs/gram of liver. This underlies the higher mortality rate among BRD509E-
injected MyD88
-/-
 mice that began to be manifested by 3-4 weeks post infection (Fig. 
4). Importantly, even in a background of significant immunodeficiency, the extent of 
proliferation observed with the GIDIFN strain in MyD88
-/-
 mice was significantly 
lower than that of BRD509E, remaining mostly below septic threshold levels. It 
appears, therefore, that the expression of IFN- by Salmonella facilitates their more 
efficient elimination, thereby leading to a decrease in host mortality. Similar findings 
were found when bacterial loads were compared in infected WT vs. IFN-/- mice 
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(Fig. 6).  In contrast to WT mice that controlled the infection and had very low 
bacterial loads in the liver (<1 CFU/mg), IFN-/- mice exhibited 94-, 1900-, and 
78,500-fold higher BRD509E CFUs at 7, 10 and 14 days post infection, respectively. 
Despite the heightened susceptibility of IFN-/- mice, bacterial liver CFUs of 
GIDIFN were significantly lower (1.7 to 3.7-fold) than the corresponding BRD509E 
loads. Thus, the enhanced survival of GIDIFN-infected mice correlates with 
decreased bacterial burden in systemic organs.  
 
 
 
 
 
 
 
 
 
Figure 5: Rapid clearance of IFN-expressing Salmonella in vivo. 
WT (A-B) and MyD88
-/-
 (C-D) mice were inoculated i.p with ~0.5x 10
6
 
CFUs/mouse and at indicated time points were sacrificed and the bacterial load 
in spleens (A/C) and livers (B/D) enumerated. Each data point represents the 
mean ± SEM of 8-15 mice per group. Asterisks denote statistically significant 
differences between BRD509E and GIDIFN-infected mice (*p ≤0.05, **p 
≤0.01, ***p ≤0.0001). 
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3.3. Induction of splenomegaly 
The degree of splenomegaly induced by infection with BRD509E or GIDIFN 
in different mouse strains was assessed. The data for MyD88
-/-
 vs. WT mice 
comparison is shown in Figure 7. In both mouse strains, maximum splenomegaly 
was observed on day 14 post infection. Despite the fact that the degree of 
splenomegaly was relatively greater in MyD88
-/-
 mice, there was a delay in the 
induction of this response early in infection. This is seen when one examines 
splenomegaly induced on day 3 post infection in both mouse strains. While the mean 
spleen weight of infected mice increased by 2.5 to 3.0-fold in WT mice, the mean 
weights in MyD88
-/-
 mice represented about 1.6-fold compared to non-infected 
Figure 6: Decreased bacterial load of IFN-expressing Salmonella in vivo. 
 WT (A) and IFN-/- (B) mice were inoculated i.p with ~300 CFUs/mouse and at 
indicated time points were sacrificed and bacterial load in livers enumerated. 
Each data point represents the mean ± SEM of 3-6 mice per group. Asterisks 
denote statistically significant differences between BRD509E and GIDIFN 
infected mice (*p < 0.05; **p < 0.01; ***p < 0.001). Compiled from 4 
independent experiments. 
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animals. Another consistent observation was that the degree of splenomegaly 
induced by GIDIFN was uniformly less than that induced by the BRD509E strain 
(Fig. 7A-B). This may well be related to the above-discussed differences in bacterial 
loads in target organs, including the spleen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A similar picture could be observed when we compared splenomegaly in 
infected WT vs. IFN-/- mice (Fig. 8A-B). In contrast to WT mice that had a 
controlled level of splenomegaly, BRD509-infected IFN-/- mice exhibited 1.3- and 
2.5-fold higher splenomegaly at 10 and 14 days post infection, respectively. A 
similar pattern of splenomegaly was observed in GIDIFN-infected IFN-/- mice; 
Figure 7: Infection-induced splenomegaly in Salmonella-injected mice.  
Animal were inoculated with ~0.5 x 10
6 
CFUs/mouse of BRD509E or GIDIFN 
strain. At days 3, 7 and 14, spleens were aseptically removed WT (A) and 
MyD88
-/- 
(B) mice and weighted. Each data point represents the mean ± SEM of 
5 mice per group. Asterisks denote statistically significant differences between 
BRD509E and GIDIFN infected mice (*p < 0.05; **p < 0.01; ***p < 0.001). 
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however, the extent of the increased spleen weights was in general lower (~10%) 
than in BRD509E-infected mice. 
 
 
 
 
 
3.4. Enumeration of peritoneal cavity cellularity  
Recruitment of inflammatory cells was investigated through enumeration of 
peritoneal cells harvested from WT and IFN-/- mice following infection with 
BRD509E or GIDIFN as shown in Figure 9. Infection with BRD509E results in 
recruitment of inflammatory cells at similar levels in both mouse strains (Fig. 9A-B). 
Interestingly, infection with GIDIFN causes influx in peritoneal cells as early as 20 
Figure 8: Infection-induced splenomegaly in Salmonella-injected mice. 
Animal were inoculated with ~300 CFUs/mouse of BRD509E or GIDIFN strain. 
At days 7, 10 and 14, spleens were aseptically removed from WT (A) and IFN-/- 
(B) mice and weighted. Each data point represents the mean ± SEM of 3-6 mice 
per group. Compiled from 4 independent experiments. Asterisks denote 
statistically significant differences between BRD509E and GIDIFN infected 
mice (*p < 0.05; **p < 0.01; ***p < 0.001). 
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hours post infection, that continues to increase in IFN-/- mice while it normalizes in 
WT after 48 hours post infection (Fig. 9A-B). Thus, the expression of IFN- by 
GIDIFN correlates with the enhancement in the cellularity of peritoneal cells. 
 
 
 
 
 
 
 
 
 
Figure 9: GIDIFN enhances the recruitment of peritoneal cells. 
(A-B) WT and IFN-/- mice were infected i.p with 1x106 CFUs/mouse of 
BRD509E (A) or GIDIFN (B), and the number of total peritoneal exudate 
cells (PEC) was enumerated at indicated time points. Each data point 
represents the mean ± SEM of 3-5 mice per group. 
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3.5. Phenotypic analysis of recruited cells in the peritoneal cavity post 
inoculation with Salmonella 
The ratios of different cell sub-populations in the peritoneal cavity 4 and 48 
hours after infection with either BRD509E or GIDIFN were next analyzed. 
Peritoneal exudate cells from saline-injected mice were used as control. Specifically, 
the aim was to ascertain if there were any changes in cell composition in the two 
groups of infected animals as compared to control. Moreover, the extent and makeup 
of the inflammatory cell infiltrates into the peritoneal cavity was determined. The 
results of this analysis are shown in Figures 10-11. 
Flow cytometric analysis using PE-cy7-conjugated CD19, APC-cy7-
conjugated CD11b and PE-conjugated Gr1 mAbs is shown in Figures 10-11. In 
uninfected WT mice, four populations were observed; 20% CD19
+
 CD11b
+
 (B1 
cells) and 62% CD19
-
 CD11b
+
 (myeloid cells), which represents myeloid cells that is 
sub-divided according to the expression of Gr1 surface antigen into: 26% Gr1
+
 
CD11b
+
 (granulocytes) and 36% Gr1
-
 CD11b
+
 (macrophages) (Fig. 10A/D).  
Upon infection with BRD509, the ratio of myeloid cells increases slightly 
(62% to 68%) at 4 hours, then increases to 92% 48 hours post-infection (Fig. 10G). 
The increase in myeloid cells observed with BRD509E, is presented by the same 
increase of the myeloid sub-populations, with a high increase after 48 hours post 
infection (Fig. 10H-I). Moreover, the increase of myeloid cells in infected mice, 
corresponds with decease in the ratio of B1 cells that is 6.7- 4.7- fold decrease 48 
hours post-infection with BRD509E or GIDIFN, respectively (Fig. 10J). Similar 
findings were observed with GIDIFN (Fig. 10H-J). By contrast, in uninfected IFN-/- 
mice, the ratio of myeloid cells is 1.7- fold less than WT, with most of myeloid cells 
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comprise of macrophages (35%) compared to the granulocytes (1%), while the ratio 
of B1 cells remains similar (19%) (Fig. 11A/D). upon infection with BRD509E, the 
ratio of myeloid cells increases to 60% 4 hours post-infection, and remains at similar 
ration after 48 hours of infection (Fig. 11G). This increase, is mostly in the 
granulocytes with the ratio getting to 26%, then drops to 5.3% after 4 and 48 hours 
post-infection, respectively (Fig. 11H). While the ratio of macrophages remains the 
same in both infection time points (Fig. 11I). Interestingly, the ratio of myeloid cells 
shows 1.5- fold increase in GIDIFN-infected mice compared to BRD509 48 hours 
post infection. This increase is marked by the granulocytes, that is 50-fold and 9.3-
fold higher than uninfected and BRD509E-infected mice, respectively (Fig. 11G-I). 
Moreover, infection with either strains causes a decrease in the B1 cell ratios 48 
hours post-infection, that is least in GIDIFN-infected mice (19% to 10% and 19% to 
3.5%) (Fig. 11G). 
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3.6. Phenotypic analysis of cell populations in the spleen of Salmonella infected 
mice 
We further assessed the ratios of different cell sub-populations in systemic 
organ (spleen) 7 days after infection with BRD509E or GIDIFN. As in the above, 
spleen cells from saline-injected mice were used as control, and analysis was based 
on comparing the changes of cell composition in the two groups of infected mice to 
control mice. The results of this analysis are shown in Figures 13-14. 
Flow cytometric analysis using FITC-conjugated CD3, PE-cy7-conjugated 
CD19, APC-cy7-conjugated CD11b and PE-conjugated Gr1 mAbs is shown in 
Figures 13-14. In uninfected WT mice, cells comprising the spleen were identified 
as follows; 50% CD19
+
 (B cells), 30% CD3
+
 (T cells) and 12% CD19
- 
CD3
-
 
(myeloid cells) (Fig. 13A). Myeloid cells sub-populations are identified by their 
surface expression of Gr1 into: 4.4% Gr1
+ 
CD11b
+
 (granulocytes) and 7.6% Gr1
-
 
CD11b
+
 (macrophages) (Fig. 13D). Upon infection with BRD509E, the ratio of 
myeloid cells increases 2.6-fold, with almost similar increase in the ratios of 
granulocytes and macrophages (3.2-fold and 2.2-fold, respectively) compared to 
uninfected mice (Fig. 13G-H). Similar findings were observed in GIDIFN-infected 
mice, in the matter of fold increase to uninfected and compared to BRD509E (Fig. 
13G-H). Infection with BRD509E or GIDIFN cause a 1.3-fold decrease in the ratio 
of B cells compared to uninfected mice (Fig. 13J). Similarities in the cell ratios 
observed were correlated to the spleen weight and absolute count values (Fig. 12A-
B). 
Data obtained from IFN-/- mice showed similar findings, in the matter of cell 
ratios to uninfected mice and between the two bacterial strains (Fig. 14G-I). 
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Nevertheless, GIDIFN-infected mice showed a 1.3-fold increase in the ratio of 
granulocytes compared to BRD509E (Fig. 14H). Finally, comparison of the absolute 
cell counts between the WT and IFN-/-, shows similarities in all cells, except for B 
cells which is 1.5-fold more in WT than IFN-\- (Fig. 13K-N & Fig. 14K-N), which 
correlates with the higher total spleen cell counts in WT than IFN-\- mice (Fig. 12A-
B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Infection induced splenomegaly in Salmonella-injected WT and IFN-/- 
mice. 
 Animals were inoculated with ~1x10
6
 CFUs/mouse of BRD509E or GIDIFN 
strain, and spleens were aspectically removed at day 7 post infection. Data 
presented as spleen weights and absolute splenocyte count for WT (panels A-B) 
and IFN-/- (panels C-D). Each data point represents the mean ± SEM of 3-4 mice 
per group. Asterisks denote statistically significant differences between BRD509E and 
GIDIFN infected mice (*p < 0.05; **p < 0.01; ***p < 0.001). 
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3.7. Antimicrobial effect of GIDIFN on ex vivo-cultured peritoneal exudate cells 
We assessed the activation status of macrophages in response to Salmonella 
infection. Nitric oxide (NO) is an essential anti-microbial compound produced by 
activated macrophages in response to Salmonella infection. Thioglycolate-elicited 
peritoneal exudate cells were harvested from WT and IFN-/- mice and cultured with 
BRD509E or GIDIFN organisms, as described in methods section. Four hours after 
initiation of culture, cell-free supernatants were collected and analyzed for NO 
content by the Griess assay. As shown in Figure 15, the extent of NO production 
was dependent on the bacterial dose used in culture, judging by the increased NO 
response as the multiplicity of infection (MOI) increases. WT mice infected with 
BRD509E shows increasing level of NO response of 5.6mM, 8.2mM and 54.9mM 
corresponding to 5:1, 30:1 and 60:1 MOI, respectively (Fig. 15A). The response 
elicited by GIDIFN Salmonella strain was superior to with BRD509E, with 1.9-fold 
and 1.3-fold increase in 30:1 and 60:1 MOI, respectively (Fig. 15A). By contrast, NO 
response in IFN-/- mice shows similar trend in the increased level in correspondence 
to MOI, with GIDIFN Salmonella strain showing superiority in level of NO response 
observed as a 1.8-fold and 2-fold increase compared to BRD509 at 30:1 and 60:1 
MOI, respectively (Fig. 15B).  
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Finally, we compared the gene expression profiles of cells from the above ex-
vivo experiment in the expression of NO gene regulator (iNOS) and S100A9 (an 
early inflammatory marker). Data of fold change and relative expression of WT and 
IFN-/- mice are shown in Figure 16. Starting with iNOS, BRD509E-infected WT 
cells, shows a minor increase in the expression of iNOS presented as 1.25-fold 
increase compared to saline-treated group (Fig. 16A/C). On the other hand, GIDIFN-
infected cells, shows superiority with 8.8-fold and 7-fold increase compared to 
uninfected and BRD509E-infected cells, respectively (Fig. 16A/C). Remarkably, the 
expression of iNOS in IFN-/- mice is much higher than WT, with 15.7-fold and 73.7-
fold higher gene expression in BRD509E and GIDIFN infected cells, respectively 
Figure 15: Enhanced production of NO from PECs infected ex-vivo by GIDIFN. 
Thioglycolate elucidated PEC were harvested from WT (A) and IFN-/-  (B)  and 
infected for 1 hour with BRD509E or GIDIFN in antibiotic-free medium at 
different MOI. At the end of the infection period, non-internalized bacteria were 
killed with gentamicin, and cells were further incubated for 4 hours, after which 
cell-free culture supernatants were collected and analyzed for nitrite content using 
the Greiss method. Each data point represents the mean ± SEM of the 
supernatants  of  5 ex vivo independent experiments. One way ANOVA was used 
to calculate statistical difference. 
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(Fig. 16E/G). In addition, GIDIFN infected to IFN-/- mice, express iNOS 648.6-fold 
higher than control, and 33.1-fold higher than BRD509E-infected cells of the same 
mouse strain (Fig. 16E/G). 
Next, S100A9 gene expression of WT cells shows high level of expression in 
response to Salmonella infection, presented as 25.4-fold and 34.3-fold increase of 
BRD509E and GIDIFN, respectively as compared to control. Moreover, GIDIFN 
express the gene 1.3-fold higher than BRD509E (Fig. 16B/D). By contrast, IFN-/- 
cells expressed the S100A9 gene in a similar trend as in the WT when compared to 
control, with the exception of GIDIFN expressing the gene 0.5-fold lower than 
BRD509E (Fig. 16F/H). Interestingly, the expression of S100A9 by WT is far more 
than IFN-/-, which could suggest that expression of this gene is impaired in the 
absence of IFN- (Fig. 16B/D; F/H)


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Figure 16: Enhanced antimicrobial gene expression of GIDIFN infected cells. 
Thioglycolate elucidated PEC were harvested from WT (A-D) and IFN-/-  (E-H)  
and infected  for 1 hour with BRD509E or GIDIFN in antibiotic-free medium at 
5:1 MOI. At the end of the infection period, non-internalized bacteria were 
killed with gentamicin, and cells were further incubated for 4 hours. Cells were 
analyzed for their gene expression by RT-PCR for iNOS and S100A9. Data is 
presented as fold change compared to the non-infected sample for the WT on the 
left panel (A-B) and IFN-/-  on the right panel (E-F), or as relative expression of 
mRNA of WT (C-D) and IFN-/-  (G-H). Each data represents the gene 
expression of one experiment.  
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Chapter 4: Discussion 
Our lab has previously demonstrated the immune-potentiating properties of 
GIDIFN, a recombinant derivative of the attenuated aroA/aroD double auxotrophic 
mutant BRD509E, which has been engineered to express murine IFN- under the 
control of nirB promoter (al-Ramadi et al., 2001). Recently, GIDIFN was shown to 
be a more efficient vaccine candidate in two different immunodeficient mouse 
models, the C3H/HeJ (TLR4
-/-
 Nramp1
R
) and CD154
-/- 
(TLR4
+/+
 Nramp1
S
) mice (Al-
Ojali et al., 2013; Al-Ojali et al., 2012).  
In the present study, IFN-expression by an attenuated Salmonella strain, 
GIDIFN, was able to modulate the immune response of two hypersusceptible mouse 
strains, MyD88-deficient (MyD88
-/-
) and IFN--deficient (IFN-/-) mice. This 
provides support for the notion that cytokine-expressing, vaccine, strains of 
Salmonella may be more amenable for use in immunodeficient hosts in comparison 
with the parental, non-cytokine-expressing strain. 
4.1. IFN- expression by GIDIFN enhances the survival of extremely susceptible 
IFN-/- mice 
Salmonella is a facultative intracellular pathogen that causes systemic typhoid 
infection. Virulence of these organisms is linked to their capacity to penetrate the 
intestinal epithelium and target the phagocytic cells as its replication niche inside a 
compartment called Salmonella containing vacuole (SCV) (Chakravortty, 2002). 
Controlling bacterial replication at this stage is a decisive factor in determining the 
susceptibility of the host to Salmonella infection. This is in part controlled by the 
Nramp1 gene, an innate resistance trait for Salmonella infection (Gruenheid & Gros, 
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2000; Lang et al., 1997). Nramp1 is essential in resistance to salmonella infection 
through the enhancement of phagocytic cell recruitment and phagocytosis process of 
intracellular pathogen (Soo et al., 1998). Hosts with mutated Nramp1 as, in the case 
of C57BL/6 mice, are considered susceptible to Salmonella due to the reduced 
macrophage killing efficacy (Govoni et al., 1999).  
Immunity to Salmonella is accomplished through a robust Th1 response, that 
is mainly dependent on IFN-, that would regulate the other components of the 
immune system to clear the infection (Shtrichman & Samuel, 2001; al-Ramadi et al., 
2006). The role of IFN- in susceptibility to Salmonella was first demonstrated in a 
study in which depletion of IFN by a specific mAb resulted in increased 
susceptibility of naturally resistant mice, with bacteria proliferating systemically and 
mice succumbing to infection after a week of infection (Nauciel & Espinasse-Maes, 
1992). Furthermore, Bao and colleagues demonstrated the susceptibility of IFN- 
deficient mice in an oral infection model using 5 x 10
8 
CFUs of BRD509E strain, 
which resulted in disseminated septicemia two weeks later (Bao et al., 2000).   
In the current study, IFN- deficient mice were tested for their differential 
susceptibility to BRD509E and GIDIFN strain. Our results show that mice infected 
with a very low dose of 300 CFUs/mouse via the i.p. route succumb to the infection 
by day 28 post inoculation. These results emphasize the role of IFN- in immunity to 
attenuated Salmonella. Accordingly, we hypothesized that IFN--expression by the 
recombinant GIDIFN strain could compensate for the lack of IFN- and induce a 
better immune response in IFN- deficient hosts.  
Compared to BRD509E, GIDIFN strain significantly enhanced the survival 
of IFN--deficient mice infected i.p with the same dose. Susceptibility of IFN--
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deficient mice to BRD509E is associated with a loss of bacterial control in target 
organs. As shown here, even at a dose of 300 CFUs/mouse, the bacterial burden in 
the liver of IFN--deficient mice was 94-, 1900-and 78,500-fold higher than WT 
mice at 7, 10 and 14 days post infection, respectively. Although the expression of 
IFN- by GIDIFN was not enough to provide the same level of bacterial control as in 
WT mice, it nevertheless resulted in a significantly reduced bacterial burden in the 
liver compared to the BRD509E strain that was observed at early time points 
following infection. This is consistent with early identification of IFN- as a key 
regulator of innate immunity to Salmonella infection (Hess et al., 1996). 
The effect of GIDIFN on susceptibility of MyD88-deficient mice was also 
investigated. Many studies have shown the susceptibility of these mice to bacterial 
and viral infections (Scanga et al., 2002; Lund et al., 2003). Furthermore, mice 
lacking MyD88 are highly susceptible to attenuated strains of S. typhimurium due to 
their inability to control systemic bacterial spread and growth in target organs, 
accompanied with delayed recruitment of phagocytic cells, and defective cytokine 
production (Issac et al., 2013; al-Ramadi et al., 2004).  
As an adaptor molecule for the signaling pathways of most TLRs and other 
proinflammatory cytokines, such as IL-2 and IL-18, MyD88 has a great impact in the 
initiation of anti-Salmonella immune response through the production of these 
proinflammatory cytokines (Raupach et al., 2006). MyD88
-/-
 mice exhibited 
increased susceptibility to attenuated Salmonella, with an overall survival rate of 
only 30% when given a low dose of 10
3
 CFUs/mouse i.p. In sharp contrast, infection 
with GIDIFN resulted in a significant enhancement with ~90% of the infected 
animals surviving a similar dose infection. The enhancement in survival was 
associated with better control of bacterial replication in target organs. 
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A comparison of host susceptibility in the two immunodeficient mouse 
models clearly shows that IFN--/- mice are far more susceptible than MyD88-/- 
counterparts. Infection of IFN--/- mice with a dose that was 3 fold lower than the 
lowest dose used in MyD88
-/-
 mice (300 vs. 1000 CFUs/mouse) still resulted in 
earlier and more pronounced mortality in the former mouse strain. The fact that 
GIDIFN could enhance the survival of these extremely susceptible animals is an 
indication of the potential significance of this strategy to boost anti-bacterial 
immunity in susceptible hosts.  
4.2. GIDIFN enhances the recruitment of peritoneal myeloid cells 
Early recognition of a pathogen is the first stage of the early innate immune 
response. In the case of Salmonella infection, phagocytes can sense the presence of 
Salmonella through the recognition by TLRs of Salmonella-associated PAMPs, 
including lipopolysaccharide (by TLR4), bacterial lipoproteins (TLR2), flagellin 
(TLR5) and CPG DNA (TLR9) (Knapp, 2010). Activation of TLRs leads to the 
production of proinflammatory cytokines such as TNF-, IL-6 and IL-12 in a 
MyD88-dependent manner through the activation of transcription factor NF-B 
(Akira & Takeda, 2004). 
Phagocytic cells, including macrophages, neutrophils and dendritic cells, are 
crucial during the early stage of an infection for the control of bacterial growth and 
recruitment of other immune cells by production of cytokines and chemokines. 
Cytokines such as IL-12 mediates immunity to Salmonella through the induction of 
IFN- production by NK cells and facilitates the development of a Th1 response 
(Castro et al., 1995; Manetti et al., 1993).  
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Flow cytometric analysis of peritoneal cells collected at 4 hr or 48 hr after 
infection with BRD509E or GIDIFN Salmonella strain revealed the superior capacity 
of GIDIFN to recruit myeloid inflammatory cells. This was particularly observed by 
the sustained increase in these cells at 48 hr post inoculation. Previous studies have 
ascribed a role for IFN- in controlling neutrophil influx through regulating the 
chemokine secretion in response to microbial triggers as well as modulating the 
expression of chemokine receptors (Robson et al., 2001; Bonecchi et al., 1999). In 
our study, hypersusceptibility of IFN--/- mice to Salmonella infection could be partly 
due to defective recruitment of inflammatory cells. This is consistent with a study in 
which a defect in IFN- impaired neutrophil recruitment, which was restored upon 
treatment with recombinant IFN- through normalization of PMN-activating CXC 
chemokine expression (McLoughlin et al., 2003). 
A comparison of the phenotypic changes at later time points in a systemic 
organ (spleen) between BRD509E or GIDIFN-infected WT and IFN--/- mice 
surprisingly shows no difference in the extent of myeloid cell recruitment induced by 
either bacterial strain, suggesting that the observed GIDIFN-mediated enhancement 
is most likely due to its effect at the early phase of infection. 
4.3. GIDIFN enhances the anti-microbial effector functions of macrophages 
Salmonella is an intra-macrophage pathogen and elimination of such a 
microbe requires the activation of bacteria-infected macrophages through IFN-. This 
activation induces the bactericidal process through the production of nitric oxide 
(NO) and reactive oxygen radicals resulting in increased access of the lytic effector 
molecules to the salmonella containing vacuole (Richter-Dahlfors et al., 1997). In 
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addition, IFN- enhances antigen presentation via MHC class II and stimulate NK 
cells to produce more IFN- and NO via IL-12 production (Liew, 1995). Nitric oxide 
has an important role in the killing process of different microbes. Liew and his group 
demonstrated the effect of IFN- activated macrophages in killing intracellular 
leishmania parasites by NO, which could be inhibited through the addition of a 
compound (L-NMMA) which is an antagonist for the L-arginine necessary for the 
NO production pathway (Liew et al., 1990). Another study have shown the effect of 
neutralizing IL-12 in the dissemination of Salmonella to target organs, due to 
reduced level of serum IFN- and downregulation of MHC class II and iNOS (Nitric 
oxide synthase), all of which reversed upon treatment with recombinant IFN- 
(Mastroeni et al., 1998).  
In the present study, co-culture of GIDIFN with PECs induced an 
enhancement in the level of NO and upregulated iNOS gene expression. In fact, co-
culture of WT PECs with BRD509E at MOI of 5:1 for 1 hr failed to increase iNOS 
gene expression to any significant level above control. However, when GIDIFN was 
used at the same culture conditions, there was a dramatic 7-fold increase in iNOS 
expression. Similar findings were observed when IFN-/- PECs were used, with 
GIDIFN strain enhancing iNOS expression by 30-fold over the level seen in cells 
cultured with BRD509E strain. Together with previous studies, these findings 
suggest that IFN- expression by GIDIFN enhances the ability to activate effector 
macrophages even in IFN-/- mice. These findings are consistent with previous data 
from our laboratory that reported the effect of GIDIFN on peritoneal cells harvested 
from thioglycolate-injected BALB/c mice. The capacity of GIDIFN to induce 
macrophage activation as evidenced by upregulated expression of macrophage 
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activation markers, strong induction of proinflammatory cytokines including, TNF-
, IL-6 and IL-12 and increased production of antimicrobial effector molecules, 
including NO (Fernandez-Cabezudo et al., 2009).  
Another marker used to assess macrophage activation is S100A9, which is a 
protein expressed on phagocytes that first infiltrate inflammatory sites (Nacken et al., 
2003). S100A9 has an important role in neutrophil recruitment in response to LPS 
stimulation (Vandal et al., 2003). S100A9 is an important recognition molecule of 
endogenous danger signals in phagocytes and regulates myeloid cell function by 
binding to TLR-4 (Vogl et al., 2007; Ehrchen et al., 2009). S100A9 dimerizes with 
S100A8 to form a complex (known as calprotectin), which is found predominantly in 
myeloid cells, and is actively secreted in response to stress in phagocytic cells 
(Markowitz et al., 2013). In one study, S100A9 was reported to act as an inducer of 
nitric oxide production by murine macrophages in iNOS-dependent manner (Pouliot 
et al., 2008).  In addition, this study showed that S100A9 and IFN- have a 
synergistic effect on nitric oxide generation, suggesting an important role of S100A9 
in cytokine-mediated activation of phagocytes during the innate immune response 
and its effect on modulating antimicrobial functions (Pouliot et al., 2008).   
Analysis of S100A9 gene expression in BRD509E- vs. GIDIFN-treated PECs 
yielded a different picture. In this case, expression of S100A9 was predominantly 
induced by co-culture of PECs with BRD509E bacteria, resulting in 25- and 30-fold 
increase over control in WT and IFN-/- PECs, respectively. Similar cultures with the 
GIDIFN bacterial strain showed either a modest increase (~1.3-fold in WT) or 
decrease (~1.7-fold in IFN-/-) compared to BRD509E. These data demonstrate the 
co-requirement for TLR-mediated signaling and IFN- in the optimal activation of 
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iNOS. In contrast, S100A9 induction appears to be dependent on TLR signals but 
mostly independent of IFN-.  
In summary, this study demonstrated the capacity of a genetically-engineered, 
IFN-expressing Salmonella strain (GIDIFN) to significantly enhance the survival of 
two immunodeficient, Salmonella-hypersusceptible mouse strains, namely MyD88
-/-
 
and IFN--/- mice. This enhancement was correlated with decreased bacterial loads in 
systemic organs, possibly due to the enhanced ability of GIDIFN to activate effector 
macrophages, as shown by increased synthesis of anti-microbial effector molecules, 
including NO. These findings suggest the potential use of attenuated bacterial strains 
expressing immunomodulatory genes as a therapeutic approach in immunodeficient 
hosts. 
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